4D Molecular Therapeutics
FDMT
$25.34
Share price
-1.17%
Change (1 day)
39.38%
Change (1 year)
Categories
P/S ratio for 4D Molecular Therapeutics (FDMT)
P/S ratio as of May 2024 (TTM): 64.0
According to 4D Molecular Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 63.9743. At the end of 2023 the company had a P/S ratio of 41.8.
P/S ratio history for 4D Molecular Therapeutics from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 41.8 | -81.83% |
| 2022 | 230 | 488.37% |
| 2021 | 39.1 | -51.55% |
| 2020 | 80.7 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |